{"id":660010,"date":"2025-02-05T00:00:00","date_gmt":"2025-02-05T00:00:00","guid":{"rendered":"https:\/\/enterpriseam.com\/egypt\/2025\/02\/05\/ebrd-exits-ibnsina-pharma\/"},"modified":"2025-02-05T00:00:00","modified_gmt":"2025-02-05T00:00:00","slug":"ebrd-exits-ibnsina-pharma","status":"publish","type":"post","link":"https:\/\/enterpriseam.com\/egypt\/2025\/02\/05\/ebrd-exits-ibnsina-pharma\/","title":{"rendered":"EBRD exits Ibnsina Pharma"},"content":{"rendered":"

EBRD has fully exited its investment in Ibnsina Pharma: <\/strong>The European Bank for Reconstruction and Development (EBRD) has sold the last 8.8% it held of EGX-listed pharma distributor Ibnsina Pharma, the lender said yesterday<\/a>. <\/p>\n

(Tap or click the headline above to read this story with all of the links <\/strong>to our background as well as external sources.)<\/p>\n

The price tag: <\/strong>EBRD didn\u2019t disclose the value of the sale, but EGX yesterday said<\/a> an EGP 555.5 mn transaction was executed on Ibnsina Pharma\u2019s shares. Some 88.9 mn shares were sold. <\/p>\n

A successful investment: <\/strong>Since the EBRD invested in the company, it has \u201cgrown strongly, becoming the top pharma distributor in the Egyptian market and successfully expanding into a number of non-pharma operations.\u201d<\/p>\n

By the numbers: <\/strong>Ibnsina Pharma currently holds a 30.8% share of the national pharma distribution market. It also led Egypt\u2019s pharma and hospitals sector last year and ranked first in public and private hospitals, the company said in a release (pdf)<\/a> earlier this week. <\/p>\n

What they said:<\/strong> \u201cIbnsina Pharma has been an incredibly successful investment for the Bank, despite the very challenging Egyptian macro environment,\u201d said our friend Hassan Massoud, the bank\u2019s associate director for private equity in the Southern Mediterranean. \u201cThe scale and timing of this transaction is testament to the depth of the EGX as a credible exit venue for successful private equity investments,\u201d he continued.<\/p>\n

Remember: <\/strong>The EBRD acquired a 20% stake in the pharma player back in 2015 to help the company fund the development of warehouses, distribution centres and overall supply chain. <\/p>\n

EBRD is still long Egypt: <\/strong>The bank\u2019s other investments here include a who\u2019s-who of corporate Egypt, including Infinity, Hassan Allam Renewable Energy, GlobalCorp, and Tamweely. It has previously been an investor in a leading national hospitals group and has invested some EUR 13.8 bn here since 2012. <\/p>\n","protected":false},"excerpt":{"rendered":"

The EBRD acquired a 20% stake in the pharma player back in 2015<\/p>\n","protected":false},"author":1,"featured_media":660011,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"newspack_ads_suppress_ads":false,"newspack_popups_has_disabled_popups":false,"newspack_sponsor_sponsorship_scope":"","newspack_sponsor_native_byline_display":"inherit","newspack_sponsor_native_category_display":"inherit","newspack_sponsor_underwriter_style":"inherit","newspack_sponsor_underwriter_placement":"inherit","ep_exclude_from_search":false,"_primary_brand":0,"newspack_featured_image_position":"","newspack_post_subtitle":"","newspack_article_summary_title":"Overview:","newspack_article_summary":"","newspack_hide_updated_date":false,"newspack_show_updated_date":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[7363],"tags":[571,72,1414,7128,427],"brand":[],"newspack_spnsrs_tax":[],"class_list":["post-660010","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ma-watch","tag-ebrd","tag-enterpriseam","tag-ibnsina-pharma","tag-ma-watch","tag-pharma","wpautop","entry"],"acf":{"mongo_id":"4d3e6315-4890-4ded-a61d-f1029dd61f30","order":"5","is_powered_by":false,"story_type":"1","photo_url":"https:\/\/ent.news\/2025\/2\/385.jpg","photo_position":"above","homepage_title":"","full_issue_title":"EBRD exits Ibnsina Pharma","related_issue":[660002],"teaser":"The EBRD acquired a 20% stake in the pharma player back in 2015","voice_url":"https:\/\/s3.us-east-1.amazonaws.com\/ent.news\/audio\/2025\/2\/.d4cd8215-f425-45eb-b1be-f0d6798e95ef.mp3"},"yoast_head":"\nEBRD exits Ibnsina Pharma - EnterpriseAM Egypt<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/enterpriseam.com\/egypt\/2025\/02\/05\/ebrd-exits-ibnsina-pharma\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"EBRD exits Ibnsina Pharma\" \/>\n<meta property=\"og:description\" content=\"The EBRD acquired a 20% stake in the pharma player back in 2015\" \/>\n<meta property=\"og:url\" content=\"https:\/\/enterpriseam.com\/egypt\/2025\/02\/05\/ebrd-exits-ibnsina-pharma\/\" \/>\n<meta property=\"og:site_name\" content=\"EnterpriseAM Egypt\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-05T00:00:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/i0.wp.com\/ent.news\/2025\/2\/385.jpg?fit=%2C&ssl=1\" \/>\n<meta name=\"author\" content=\"enterpriseam admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"enterpriseam admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2025\/02\/05\/ebrd-exits-ibnsina-pharma\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2025\/02\/05\/ebrd-exits-ibnsina-pharma\/\"},\"author\":{\"name\":\"enterpriseam admin\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#\/schema\/person\/ca597032db7e4db868359c123cec256d\"},\"headline\":\"EBRD exits Ibnsina Pharma\",\"datePublished\":\"2025-02-05T00:00:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2025\/02\/05\/ebrd-exits-ibnsina-pharma\/\"},\"wordCount\":307,\"publisher\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#organization\"},\"image\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2025\/02\/05\/ebrd-exits-ibnsina-pharma\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/i0.wp.com\/ent.news\/2025\/2\/385.jpg?fit=%2C&ssl=1\",\"keywords\":[\"EBRD\",\"EnterpriseAM\",\"Ibnsina Pharma\",\"M&A Watch\",\"pharma\"],\"articleSection\":[\"M&A WATCH\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2025\/02\/05\/ebrd-exits-ibnsina-pharma\/\",\"url\":\"https:\/\/enterpriseam.com\/egypt\/2025\/02\/05\/ebrd-exits-ibnsina-pharma\/\",\"name\":\"EBRD exits Ibnsina Pharma - EnterpriseAM Egypt\",\"isPartOf\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2025\/02\/05\/ebrd-exits-ibnsina-pharma\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2025\/02\/05\/ebrd-exits-ibnsina-pharma\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/i0.wp.com\/ent.news\/2025\/2\/385.jpg?fit=%2C&ssl=1\",\"datePublished\":\"2025-02-05T00:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2025\/02\/05\/ebrd-exits-ibnsina-pharma\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/enterpriseam.com\/egypt\/2025\/02\/05\/ebrd-exits-ibnsina-pharma\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2025\/02\/05\/ebrd-exits-ibnsina-pharma\/#primaryimage\",\"url\":\"https:\/\/i0.wp.com\/ent.news\/2025\/2\/385.jpg?fit=%2C&ssl=1\",\"contentUrl\":\"https:\/\/i0.wp.com\/ent.news\/2025\/2\/385.jpg?fit=%2C&ssl=1\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2025\/02\/05\/ebrd-exits-ibnsina-pharma\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/enterpriseam.com\/egypt\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"EBRD exits Ibnsina Pharma\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#website\",\"url\":\"https:\/\/enterpriseam.com\/egypt\/\",\"name\":\"EnterpriseAM\",\"description\":\"The State of the Nation\",\"publisher\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/enterpriseam.com\/egypt\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#organization\",\"name\":\"EnterpriseAM\",\"url\":\"https:\/\/enterpriseam.com\/egypt\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ent.news\/internal\/240894.svg\",\"contentUrl\":\"https:\/\/ent.news\/internal\/240894.svg\",\"caption\":\"EnterpriseAM\"},\"image\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#\/schema\/person\/ca597032db7e4db868359c123cec256d\",\"name\":\"enterpriseam admin\",\"sameAs\":[\"http:\/\/enterpriseam.testing.projectsarea.com\"],\"url\":\"https:\/\/enterpriseam.com\/egypt\/author\/enterpriseam\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"EBRD exits Ibnsina Pharma - EnterpriseAM Egypt","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/enterpriseam.com\/egypt\/2025\/02\/05\/ebrd-exits-ibnsina-pharma\/","og_locale":"en_US","og_type":"article","og_title":"EBRD exits Ibnsina Pharma","og_description":"The EBRD acquired a 20% stake in the pharma player back in 2015","og_url":"https:\/\/enterpriseam.com\/egypt\/2025\/02\/05\/ebrd-exits-ibnsina-pharma\/","og_site_name":"EnterpriseAM Egypt","article_published_time":"2025-02-05T00:00:00+00:00","og_image":[{"url":"https:\/\/i0.wp.com\/ent.news\/2025\/2\/385.jpg?fit=%2C&ssl=1","type":"","width":"","height":""}],"author":"enterpriseam admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"enterpriseam admin","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/enterpriseam.com\/egypt\/2025\/02\/05\/ebrd-exits-ibnsina-pharma\/#article","isPartOf":{"@id":"https:\/\/enterpriseam.com\/egypt\/2025\/02\/05\/ebrd-exits-ibnsina-pharma\/"},"author":{"name":"enterpriseam admin","@id":"https:\/\/enterpriseam.com\/egypt\/#\/schema\/person\/ca597032db7e4db868359c123cec256d"},"headline":"EBRD exits Ibnsina Pharma","datePublished":"2025-02-05T00:00:00+00:00","mainEntityOfPage":{"@id":"https:\/\/enterpriseam.com\/egypt\/2025\/02\/05\/ebrd-exits-ibnsina-pharma\/"},"wordCount":307,"publisher":{"@id":"https:\/\/enterpriseam.com\/egypt\/#organization"},"image":{"@id":"https:\/\/enterpriseam.com\/egypt\/2025\/02\/05\/ebrd-exits-ibnsina-pharma\/#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/ent.news\/2025\/2\/385.jpg?fit=%2C&ssl=1","keywords":["EBRD","EnterpriseAM","Ibnsina Pharma","M&A Watch","pharma"],"articleSection":["M&A WATCH"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/enterpriseam.com\/egypt\/2025\/02\/05\/ebrd-exits-ibnsina-pharma\/","url":"https:\/\/enterpriseam.com\/egypt\/2025\/02\/05\/ebrd-exits-ibnsina-pharma\/","name":"EBRD exits Ibnsina Pharma - EnterpriseAM Egypt","isPartOf":{"@id":"https:\/\/enterpriseam.com\/egypt\/#website"},"primaryImageOfPage":{"@id":"https:\/\/enterpriseam.com\/egypt\/2025\/02\/05\/ebrd-exits-ibnsina-pharma\/#primaryimage"},"image":{"@id":"https:\/\/enterpriseam.com\/egypt\/2025\/02\/05\/ebrd-exits-ibnsina-pharma\/#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/ent.news\/2025\/2\/385.jpg?fit=%2C&ssl=1","datePublished":"2025-02-05T00:00:00+00:00","breadcrumb":{"@id":"https:\/\/enterpriseam.com\/egypt\/2025\/02\/05\/ebrd-exits-ibnsina-pharma\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/enterpriseam.com\/egypt\/2025\/02\/05\/ebrd-exits-ibnsina-pharma\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/enterpriseam.com\/egypt\/2025\/02\/05\/ebrd-exits-ibnsina-pharma\/#primaryimage","url":"https:\/\/i0.wp.com\/ent.news\/2025\/2\/385.jpg?fit=%2C&ssl=1","contentUrl":"https:\/\/i0.wp.com\/ent.news\/2025\/2\/385.jpg?fit=%2C&ssl=1"},{"@type":"BreadcrumbList","@id":"https:\/\/enterpriseam.com\/egypt\/2025\/02\/05\/ebrd-exits-ibnsina-pharma\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/enterpriseam.com\/egypt\/"},{"@type":"ListItem","position":2,"name":"EBRD exits Ibnsina Pharma"}]},{"@type":"WebSite","@id":"https:\/\/enterpriseam.com\/egypt\/#website","url":"https:\/\/enterpriseam.com\/egypt\/","name":"EnterpriseAM","description":"The State of the Nation","publisher":{"@id":"https:\/\/enterpriseam.com\/egypt\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/enterpriseam.com\/egypt\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/enterpriseam.com\/egypt\/#organization","name":"EnterpriseAM","url":"https:\/\/enterpriseam.com\/egypt\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/enterpriseam.com\/egypt\/#\/schema\/logo\/image\/","url":"https:\/\/ent.news\/internal\/240894.svg","contentUrl":"https:\/\/ent.news\/internal\/240894.svg","caption":"EnterpriseAM"},"image":{"@id":"https:\/\/enterpriseam.com\/egypt\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/enterpriseam.com\/egypt\/#\/schema\/person\/ca597032db7e4db868359c123cec256d","name":"enterpriseam admin","sameAs":["http:\/\/enterpriseam.testing.projectsarea.com"],"url":"https:\/\/enterpriseam.com\/egypt\/author\/enterpriseam\/"}]}},"featured_image_src":"https:\/\/i0.wp.com\/ent.news\/2025\/2\/385.jpg?resize=600%2C400&ssl=1","featured_image_src_square":"https:\/\/i0.wp.com\/ent.news\/2025\/2\/385.jpg?resize=600%2C600&ssl=1","author_info":{"display_name":"enterpriseam admin","author_link":"https:\/\/enterpriseam.com\/egypt\/author\/enterpriseam\/"},"jetpack_featured_media_url":"https:\/\/i0.wp.com\/ent.news\/2025\/2\/385.jpg?fit=%2C&ssl=1","jetpack_sharing_enabled":true,"jetpack-related-posts":[{"id":683327,"url":"https:\/\/enterpriseam.com\/egypt\/2026\/01\/26\/ebrd-extends-egp-1-3-bn-green-financing-to-ibnsina-pharma\/","url_meta":{"origin":660010,"position":0},"title":"EBRD extends EGP 1.3 bn green financing to Ibnsina Pharma","author":"enterpriseam admin","date":"26 January 2026","format":false,"excerpt":"The transaction comes one year after the EBRD fully exited its equity stake in Ibnsina","rel":"","context":"In "PHARMA"","block_context":{"text":"PHARMA","link":"https:\/\/enterpriseam.com\/egypt\/category\/pharma\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/2025\/2\/385.jpg?fit=%2C&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]},{"id":641334,"url":"https:\/\/enterpriseam.com\/egypt\/2017\/09\/19\/ibnsina-pharma-files-intention-to-float-on-egx\/","url_meta":{"origin":660010,"position":1},"title":"Ibnsina Pharma files intention to float on EGX","author":"enterpriseam admin","date":"19 September 2017","format":false,"excerpt":"IPO WATCH- Ibnsina Pharma announced its intention to proceed with an initial public offering (pdf) on the EGX. The company, Egypt\u2019s fastest-growing pharma distributor, is offering around 25% of its shares through both primary and secondary offerings. (You can check out its corporate website here.)The transaction will take place in\u2026","rel":"","context":"In "Speed Round"","block_context":{"text":"Speed Round","link":"https:\/\/enterpriseam.com\/egypt\/category\/speed-round\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/internal\/536550.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":635828,"url":"https:\/\/enterpriseam.com\/egypt\/2017\/12\/14\/ebrd-to-invest-eur-1-bn-in-egypt-in-2018\/","url_meta":{"origin":660010,"position":2},"title":"EBRD to invest EUR 1 bn in Egypt in 2018","author":"enterpriseam admin","date":"14 December 2017","format":false,"excerpt":"INVESTMENT WATCH- The European Bank for Reconstruction and Development (EBRD) could invest as much as EUR 1 bn in Egypt next year, the bank\u2019s Managing Director for Equity Hassan El Khatib said, according to Al Borsa. The EBRD invested EUR 1.2 bn this year in development and solar energy projects\u2026","rel":"","context":"In "Speed Round"","block_context":{"text":"Speed Round","link":"https:\/\/enterpriseam.com\/egypt\/category\/speed-round\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/internal\/536550.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":594775,"url":"https:\/\/enterpriseam.com\/egypt\/2019\/09\/08\/shareholders-sell-8-4-stake-in-egypts-ibnsina-pharma\/","url_meta":{"origin":660010,"position":3},"title":"Shareholders sell 8.4% stake in Egypt\u2019s Ibnsina Pharma","author":"enterpriseam admin","date":"8 September 2019","format":false,"excerpt":"Shareholders sell 8.4% stake in Ibnsina: Shareholders have sold 8.4% of their shares in Ibnsina Pharma, amounting to around 69.1 mn shares, at EGP 9.7-10.22 per share, according to an emailed statement from EFG Hermes (pdf). Among the sellers was the European Bank for Reconstruction and Development (EBRD), which reduced\u2026","rel":"","context":"In "Speed Round"","block_context":{"text":"Speed Round","link":"https:\/\/enterpriseam.com\/egypt\/category\/speed-round\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/2020\/4\/308.jpg?fit=%2C&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]},{"id":601203,"url":"https:\/\/enterpriseam.com\/egypt\/2019\/02\/21\/ibnsina-antitrust-fine-reduced-to-egp-160-mn-from-egp-2-04-bn\/","url_meta":{"origin":660010,"position":4},"title":"Ibnsina antitrust fine reduced to EGP 160 mn from EGP 2.04 bn","author":"enterpriseam admin","date":"21 February 2019","format":false,"excerpt":"DISPUTE WATCH- Ibnsina confirms antitrust fine reduced to EGP 160 mn from EGP 2.04 bn: Ibnsina Pharma confirmed yesterday in an EGX disclosure (pdf) that a Cairo appeals court has reduced to EGP 160 mn an original EGP 2.04 bn antitrust fine handed by the Cairo Economic Court. \u201cIbnsina Pharma\u2026","rel":"","context":"In "Speed Round"","block_context":{"text":"Speed Round","link":"https:\/\/enterpriseam.com\/egypt\/category\/speed-round\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/2019\/2\/710.jpg?fit=%2C&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]},{"id":635676,"url":"https:\/\/enterpriseam.com\/egypt\/2017\/12\/11\/ibnsina-pharma-to-begin-trading-on-egx-tomorrow-as-isph-ca-retail-offering-18-35x-oversubscribed\/","url_meta":{"origin":660010,"position":5},"title":"Ibnsina Pharma to begin trading on EGX tomorrow as ISPH.CA, retail offering 18.35x oversubscribed","author":"enterpriseam admin","date":"11 December 2017","format":false,"excerpt":"IPO WATCH- Ibnsina Pharma retail offering closes, trading to start tomorrow: Shares Ibnsina Pharma, Egypt\u2019s fastest-growing and second-largest distributor of pharmaceutical products, will begin trading on the EGX on Tuesday after the book-building process for its retail offering ended yesterday. The company\u2019s shares will trade under the stock symbol ISPH.CA\u2026","rel":"","context":"In "Speed Round"","block_context":{"text":"Speed Round","link":"https:\/\/enterpriseam.com\/egypt\/category\/speed-round\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/internal\/536550.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]}],"_links":{"self":[{"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/posts\/660010","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/comments?post=660010"}],"version-history":[{"count":0,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/posts\/660010\/revisions"}],"acf:post":[{"embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/issue\/660002"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/media\/660011"}],"wp:attachment":[{"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/media?parent=660010"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/categories?post=660010"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/tags?post=660010"},{"taxonomy":"brand","embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/brand?post=660010"},{"taxonomy":"newspack_spnsrs_tax","embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/newspack_spnsrs_tax?post=660010"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}